Alkermes plc.
ALKS
60 insider filings · Latest: Oct 8, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | Mar 2 10:07 PM | Gaffin David Joseph | Proposed Sale | 2,034 | $29.29 | $59.6K | — | View → |
| Mar 2, 2026 | Mar 2 9:36 PM | Hopkinson Craig C. | Proposed Sale | 9,000 | $29.72 | $267.5K | — | View → |
| Feb 2, 2026 | Feb 3 1:52 AM | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Sale | 9,000 | $33.93 | $305.4K | 57,740(D) | View → |
| Feb 2, 2026 | Feb 3 1:48 AM | Shane CookeDirector | Sale | 61,200 | $34.57 | $2.1M | 103,744(D) | View → |
| Feb 2, 2026 | Feb 2 9:05 PM | Cooke Shane | Proposed Sale | 61,200 | $34.57 | $2.1M | — | View → |
| Feb 2, 2026 | Feb 2 9:02 PM | Hopkinson Craig C. | Proposed Sale | 9,000 | $33.93 | $305.4K | — | View → |
| Jan 8, 2026 | Jan 9 12:38 AM | Hopkinson Craig C. | Proposed Sale | 5,000 | $30.00 | $150.0K | — | View → |
| Jan 2, 2026 | Jan 2 9:36 PM | Hopkinson Craig C. | Proposed Sale | 4,000 | $28.00 | $112.0K | — | View → |
| Dec 3, 2025 | Dec 3 9:32 PM | Hopkinson Craig C. | Proposed Sale | 3,748 | $30.00 | $112.4K | — | View → |
| Dec 1, 2025 | Dec 1 9:45 PM | Hopkinson Craig C. | Proposed Sale | 4,000 | $29.30 | $117.2K | — | View → |
| Nov 3, 2025 | Nov 3 9:35 PM | Hopkinson Craig C. | Proposed Sale | 9,000 | $30.38 | $273.4K | — | View → |
| Oct 15, 2025 | Oct 15 8:07 PM | Hopkinson Craig C. | Proposed Sale | 9,000 | $31.53 | $283.8K | — | View → |
| Jun 10, 2025 | Jun 10 8:29 PM | Nichols Christian Todd | Proposed Sale | 3,334 | $31.09 | $103.7K | — | View → |
| Jun 9, 2025 | Jun 9 8:08 PM | Nichols Christian Todd | Proposed Sale | 3,333 | $31.95 | $106.5K | — | View → |
| Feb 13, 2025 | Feb 13 9:36 PM | Hopkinson Craig C. | Proposed Sale | 144,419 | $35.53 | $5.1M | — | View → |
| Feb 12, 2025 | Feb 12 9:19 PM | Hopkinson Craig C. | Proposed Sale | 204,921 | $32.78 | $6.7M | — | View → |
| Jan 30, 2025 | Jan 30 10:12 PM | Hopkinson Craig C. | Proposed Sale | 100,918 | $32.05 | $3.2M | — | View → |
| Dec 9, 2024 | Dec 9 10:27 PM | LAURENCIN CATO T | Proposed Sale | 2,691 | $31.85 | $85.7K | — | View → |
| Dec 9, 2024 | Dec 9 10:24 PM | Hopkinson Craig C. | Proposed Sale | 61,151 | $32.07 | $2.0M | — | View → |
| Dec 5, 2024 | Dec 5 9:12 PM | Hopkinson Craig C. | Proposed Sale | 9,221 | $31.50 | $290.5K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| May 20, 2026 | May 23 12:00 AM | Cato T LaurencinDirector | Grant/Award | 16,947 | $36.98 | 5,409(D) | View → |
| May 20, 2026 | May 22 11:59 PM | Richard GaynorDirector | Grant/Award | 16,947 | $36.98 | 5,409(D) | View → |
| May 20, 2026 | May 22 11:58 PM | Shane CookeDirector | Grant/Award | 16,947 | $36.98 | 5,409(D) | View → |
| May 21, 2026 | May 22 8:59 PM | Richard GaynorDirector | Option Exercise | 6,142 | — | 0(D) | View → |
| May 20, 2026 | May 22 8:59 PM | Richard GaynorDirector | Grant/Award | 16,947 | $36.98 | 5,409(D) | View → |
| May 21, 2026 | May 22 8:57 PM | Shane CookeDirector | Option Exercise | 6,142 | — | 0(D) | View → |
| May 20, 2026 | May 22 8:57 PM | Shane CookeDirector | Grant/Award | 16,947 | $36.98 | 5,409(D) | View → |
| May 1, 2026 | May 2 1:05 AM | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Option Exercise | 5,000 | $19.34 | 11,356(D) | View → |
| Apr 11, 2026 | Apr 13 9:09 PM | Nancy LurkerDirector | Option Exercise | 3,751 | — | 3,752(D) | View → |
| Apr 1, 2026 | Apr 1 10:58 PM | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Option Exercise | 5,000 | $19.34 | 16,356(D) | View → |
| Mar 2, 2026 | Mar 5 1:21 AM | Joshua ReedSVP, Chief Financial Officer | Grant/Award | 97,284 | $30.25 | 30,854(D) | View → |
| Mar 2, 2026 | Mar 5 1:20 AM | POPS RICHARD FDirector, Director and CEO, Alkermes plc | Grant/Award | 88,843 | — | 88,843(D) | View → |
| Mar 2, 2026 | Mar 5 1:19 AM | Samuel Joseph ParisiVP, Finance (Interim PAO) | Grant/Award | 29,209 | $30.25 | 14,176(D) | View → |
| Mar 2, 2026 | Mar 5 1:18 AM | Christian Todd NicholsSVP, Chief Commercial Officer | Grant/Award | 97,284 | $30.25 | 30,854(D) | View → |
| Mar 2, 2026 | Mar 5 1:17 AM | Blair Curtis JacksonEVP, Chief Operating Officer | Grant/Award | 138,978 | $30.25 | 44,078(D) | View → |
| Mar 2, 2026 | Mar 5 1:16 AM | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Grant/Award | 121,605 | $30.25 | 38,568(D) | View → |
| Mar 2, 2026 | Mar 5 1:16 AM | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Option Exercise | 5,000 | $19.34 | 21,356(D) | View → |
| Mar 2, 2026 | Mar 5 1:15 AM | David Joseph GaffinEVP, CLO, Alkermes, Inc. | Grant/Award | 114,656 | $30.25 | 36,364(D) | View → |
| Feb 26, 2026 | Feb 27 9:40 PM | Samuel Joseph ParisiVP, Finance (Interim PAO) | Option Exercise | 2,747 | — | 5,493(D) | View → |
| Feb 26, 2026 | Feb 27 9:40 PM | Christian Todd NicholsSVP, Chief Commercial Officer | Option Exercise | 5,410 | — | 10,819(D) | View → |